Company news
Journey Medical Corporation (NASDAQ:DERM) news
Every Journey Medical Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 12, 2026
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
August 5, 2026
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 19, 2026
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 13, 2026
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
May 6, 2026
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
April 21, 2026
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
March 25, 2026
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
March 18, 2026
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi on Microbial Flora of Healthy ...
December 11, 2025
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora o...
December 10, 2025
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 12, 2025
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
November 5, 2025
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Cl...
October 24, 2025
Journey Medical Corporation to Participate in October 2025 Investor Conferences
October 8, 2025
Journey Medical Corporation to Participate in September 2025 Investor Conferences
September 3, 2025
Journey Medical Corporation to Present at the Emerging Growth Conference
August 18, 2025
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
August 12, 2025
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
August 7, 2025
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
August 5, 2025
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
July 14, 2025
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
June 24, 2025
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 202...
June 20, 2025
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
June 9, 2025
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 15, 2025
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 14, 2025
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
May 7, 2025
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
April 1, 2025
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 m...
March 24, 2025
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
March 19, 2025
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
March 12, 2025
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinica...
March 5, 2025
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
March 4, 2025
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extende...
January 23, 2025
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 12, 2024
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the T...
November 4, 2024
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
October 25, 2024
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
October 3, 2024
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
September 9, 2024
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 12, 2024
Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
August 6, 2024
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
July 17, 2024
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
July 11, 2024
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15, 2024
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 13, 2024
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
May 7, 2024
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
May 1, 2024
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
April 25, 2024
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
March 21, 2024